Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure.

British Journal of Pharmacology
María TamayoCarmen Delgado

Abstract

The synthetic vitamin D3 analogue paricalcitol acts as a selective activator of the vitamin D receptor (VDR). While there is evidence for cardioprotective effects of paricalcitol associated with the VDR pathway, less information is available about the structural and functional cardiac effects of paricalcitol on established heart failure (HF) and particularly its effects on associated electrophysiological or Ca2+ handling remodelling. We used a murine model of transverse aortic constriction (TAC) to study the effect of paricalcitol on established HF. Treatment was initiated 4 weeks after surgery over five consecutive weeks, and mice were sacrificed 9 weeks after surgery. Cardiac MRI (CMRI) was performed 4 and 9 weeks after surgery. Hearts were used for biochemical and histological studies and to isolate ventricular myocytes for electrophysiological and calcium imaging studies. CMRI analysis revealed that, compared with vehicle, paricalcitol treatment prevented the progression of ventricular dilation and hypertrophy after TAC and halted the corresponding decline in ejection fraction. These beneficial effects were related to the attenuation of intracellular Ca2+ mishandling remodelling, antifibrotic and antihypertrophic effects an...Continue Reading

References

Sep 25, 1991·Proceedings of the National Academy of Sciences of the United States of America·H A RockmanK R Chien
Feb 1, 1993·Journal of Molecular and Cellular Cardiology·D Mukherjee, S Sen
Mar 1, 1993·Cardiovascular Research·K T WeberJ S Janicki
Mar 23, 1999·Nature Medicine·H W Lim, J D Molkentin
Oct 26, 1999·Cardiovascular Research·G F Tomaselli, E Marbán
Jul 13, 2000·Cell·E N Olson, R S Williams
Jan 24, 2002·Nature·Donald M Bers
Dec 6, 2003·Circulation Research·Benjamin J WilkinsJeffery D Molkentin
Mar 12, 2004·European Journal of Heart Failure·Holger DiedrichsRobert H G Schwinger
Sep 1, 2004·Biochemical and Biophysical Research Communications·Benjamin J Wilkins, Jeffery D Molkentin
Nov 23, 2006·Physiology·Donald M Bers
Jun 1, 2007·Journal of Cardiovascular Electrophysiology·Yanggan WangJoseph A Hill
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Natalya BodyakPeter M Kang
Mar 5, 2008·Nature Clinical Practice. Cardiovascular Medicine·Robert D NassFadi G Akar
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
May 20, 2011·Circulation. Arrhythmia and Electrophysiology·Ragesh PanikkathSumeet S Chugh
Oct 1, 2011·Journal of the American College of Cardiology·Carl J LavieRichard V Milani
Jul 18, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Laura M G MeemsRudolf A de Boer
Sep 20, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Songcang Chen, David G Gardner
May 8, 2013·Cellular and Molecular Life Sciences : CMLS·Ping KongNikolaos G Frangogiannis
Sep 13, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·David G GardnerDenis J Glenn
Oct 16, 2013·Journal of Cardiac Failure·Anna J Meredith, Bruce M McManus
Jan 18, 2014·Circulation Research·P E Norman, J T Powell
Apr 1, 2015·Cardiovascular Research·Carmen DelgadoMaria Fernández-Velasco
Sep 16, 2015·The Journal of General Physiology·Gema Ruiz-HurtadoAna María Gómez
Feb 6, 2016·Circulation Research·Anjali Tiku OwensMariell Jessup
Jun 6, 2016·Journal of Molecular and Cellular Cardiology·Ippei Shimizu, Tohru Minamino
Jul 2, 2016·British Medical Bulletin·Adam NabeebaccusAjay M Shah
Jan 28, 2017·Journal of the American College of Cardiology·Almudena Val-BlascoMaría Fernández-Velasco
Aug 9, 2017·Cardiac Failure Review·Gianluigi Savarese, Lars H Lund
Sep 1, 2014·ESC Heart Failure·Piotr PonikowskiGerasimos Filippatos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.